van der Kuip H - Search Results

1

Shed human enterocytes as a tool for the study of expression and function of intestinal drug-metabolizing enzymes and transporters.

Glaeser H, Drescher S, van der Kuip H, Behrens C, Geick A, Burk O, Dent J, Somogyi A, Von Richter O, Griese EU, Eichelbaum M, Fromm MF. Glaeser H, et al. Among authors: van der kuip h. Clin Pharmacol Ther. 2002 Mar;71(3):131-40. doi: 10.1067/mcp.2002.121370. Clin Pharmacol Ther. 2002. PMID: 11907487 Clinical Trial.

2

The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells.

Hitzl M, Drescher S, van der Kuip H, Schäffeler E, Fischer J, Schwab M, Eichelbaum M, Fromm MF. Hitzl M, et al. Among authors: van der kuip h. Pharmacogenetics. 2001 Jun;11(4):293-8. doi: 10.1097/00008571-200106000-00003. Pharmacogenetics. 2001. PMID: 11434506

3

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).

Henkes M, van der Kuip H, Aulitzky WE. Henkes M, et al. Among authors: van der kuip h. Ther Clin Risk Manag. 2008 Feb;4(1):163-87. Ther Clin Risk Manag. 2008. PMID: 18728706 Free PMC article.

4

Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment.

van der Kuip H, Mürdter TE, Sonnenberg M, McClellan M, Gutzeit S, Gerteis A, Simon W, Fritz P, Aulitzky WE. van der Kuip H, et al. BMC Cancer. 2006 Apr 7;6:86. doi: 10.1186/1471-2407-6-86. BMC Cancer. 2006. PMID: 16603054 Free PMC article.

5

Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast.

Sonnenberg M, van der Kuip H, Haubeis S, Fritz P, Schroth W, Friedel G, Simon W, Mürdter TE, Aulitzky WE. Sonnenberg M, et al. Among authors: van der kuip h. BMC Cancer. 2008 Dec 11;8:364. doi: 10.1186/1471-2407-8-364. BMC Cancer. 2008. PMID: 19077243 Free PMC article.

6

The tyrosine kinase inhibitor CGP 57148 (ST1 571) induces apoptosis in BCR-ABL-positive cells by down-regulating BCL-X.

Oetzel C, Jonuleit T, Götz A, van der Kuip H, Michels H, Duyster J, Hallek M, Aulitzky WE. Oetzel C, et al. Among authors: van der kuip h. Clin Cancer Res. 2000 May;6(5):1958-68. Clin Cancer Res. 2000. PMID: 10815921

7

Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines.

Jonuleit T, van der Kuip H, Miething C, Michels H, Hallek M, Duyster J, Aulitzky WE. Jonuleit T, et al. Among authors: van der kuip h. Blood. 2000 Sep 1;96(5):1933-9. Blood. 2000. PMID: 10961897 Free article.

8

Role of poly(ADP-ribose) polymerase activity in imatinib mesylate-induced cell death.

Moehring A, Wohlbold L, Aulitzky WE, van der Kuip H. Moehring A, et al. Among authors: van der kuip h. Cell Death Differ. 2005 Jun;12(6):627-36. doi: 10.1038/sj.cdd.4401608. Cell Death Differ. 2005. PMID: 15818402

9

Adhesion to fibronectin selectively protects Bcr-Abl+ cells from DNA damage-induced apoptosis.

van der Kuip H, Goetz AW, Miething C, Duyster J, Aulitzky WE. van der Kuip H, et al. Blood. 2001 Sep 1;98(5):1532-41. doi: 10.1182/blood.v98.5.1532. Blood. 2001. PMID: 11520804 Free article.

10

Pharmacological inhibition of c-Abl compromises genetic stability and DNA repair in Bcr-Abl-negative cells.

Fanta S, Sonnenberg M, Skorta I, Duyster J, Miething C, Aulitzky WE, van der Kuip H. Fanta S, et al. Among authors: van der kuip h. Oncogene. 2008 Jul 17;27(31):4380-4. doi: 10.1038/onc.2008.68. Epub 2008 Mar 24. Oncogene. 2008. PMID: 18362889 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters